A Requirement for Fibroblast Growth Factor in Regulation of Skeletal Muscle Growth and Differentiation Cannot Be Replaced by Activation of Platelet-Derived Growth Factor Signaling Pathways
Open Access
- 1 June 1995
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 15 (6) , 3238-3246
- https://doi.org/10.1128/mcb.15.6.3238
Abstract
The distinct effects of cytokines on cellular growth and differentiation suggest that specific signaling pathways mediate these diverse biological activities. Fibroblast growth factors (FGFs) are well-established inhibitors of skeletal muscle differentiation and may operate via activation of specific signaling pathways distinct from recently identified mitogen signaling pathways. We examined whether platelet-derived growth factor (PDGF)-activated signaling pathways are sufficient to mediate FGF-dependent repression of myogenesis by introducing the PDGF beta receptor into a mouse skeletal muscle cell line. Addition of PDGF-BB to cells expressing the PDGF beta receptor activated the PDGF beta receptor tyrosine kinase, stimulated mitogen-activated protein (MAP) kinase, and increased the steady-state levels of junB and c-fos mRNAs. Despite the activation of these intracellular signaling molecules, PDGF beta receptor activation elicited no detectable effect on cell proliferation or differentiation. In contrast to PDGF-BB, addition of FGF-2 to myoblasts activated signaling pathways that resulted in DNA synthesis and repression of differentiation. Because of the low number of endogenous FGF receptors expressed, FGF-stimulated signaling events, including tyrosine phosphorylation and activation of MAP kinase, could be detected only in cells expressing higher levels of a transfected FGF receptor cDNA. As the PDGF beta receptor- and FGF receptor-stimulated signaling pathways yield different biological responses in these skeletal muscle cells, we hypothesize that FGF-mediated repression of skeletal muscle differentiation activates signaling pathways distinct from those activated by the PDGF beta receptor. Activation of PDGF beta receptor tyrosine kinase activity, stimulation of MAP kinase, and upregulation of immediate-early gene expression are not sufficient to repress skeletal muscle differentiation.Keywords
This publication has 56 references indexed in Scilit:
- Are fibroblast growth factors regulators of myogenesis in vivo?Progress in Growth Factor Research, 1994
- Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.The Journal of cell biology, 1994
- Signal transduction by the PDGF receptorsProgress in Growth Factor Research, 1994
- Fibroblast growth factor, epidermal growth factor, insulin‐like growth factors, and platelet‐derived growth factor‐BB stimulate proliferation of clonally derived porcine myogenic satellite cellsJournal of Cellular Physiology, 1993
- Interplay between proliferation and differentiation within the myogenic lineageDevelopmental Biology, 1992
- Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.The Journal of cell biology, 1990
- Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblastsBiochemistry, 1986
- Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and proteinNature, 1984
- Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomasNature, 1983
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976